ロード中...
Cdc20 overexpression is involved in temozolomide-resistant glioma cells with epithelial-mesenchymal transition
Glioma remains one of the most aggressive and lethal cancers in central nervous system. Temozolomide (TMZ) is the most commonly used chemotherapeutic agent in gliomas. However, therapeutic benefits of TMZ could be very limited and all patients would finally suffer from tumor progression as the tumor...
保存先:
| 出版年: | Cell Cycle |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5788407/ https://ncbi.nlm.nih.gov/pubmed/29108461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2017.1388972 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|